Evidence has shown that expression of PIEZO1 increased in multiple malignant diseases including bladder carcinoma, synovial sarcoma, osteosarcoma, breast cancer and gastric cancer12,46–49. This evidence concerns the gene PIEZO1 and synovial sarcoma.